Predicting Aggressive Multiple Sclerosis With Intrathecal IgM Synthesis Among Patients With a Clinically Isolated Syndrome

Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series

(2020) Mattia Fonderico et al.   Multiple Sclerosis Journal

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

(2020) Anna He et al.   LANCET NEUROLOGY

Initial high-efficacy disease-modifying therapy in multiple sclerosis: A nationwide cohort study

(2020) Mathias Due Buron et al.   NEUROLOGY

Cerebrospinal fluid oligoclonal IgM test in routine practice: Comparison with quantitative assessment of intrathecal IgM synthesis

(2020) David Zeman et al.   CLINICA CHIMICA ACTA

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

(2019) J. William L. Brown et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

(2019) Katharine Harding et al.   JAMA Neurology

Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis

(2019) Christiane Gasperi et al.   JAMA Neurology

Early highly effective versus escalation treatment approaches in relapsing multiple sclerosis

(2019) Daniel Ontaneda et al.   LANCET NEUROLOGY

Intrathecal immunoglobulin M production: A promising high-risk marker in clinically isolated syndrome patients

(2018) André Huss et al.   ANNALS OF NEUROLOGY

Clinical usefulness of prognostic biomarkers in optic neuritis

(2018) A. Tejeda-Velarde et al.   EUROPEAN JOURNAL OF NEUROLOGY

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

(2018) Alan J Thompson et al.   LANCET NEUROLOGY

Unraveling treatment response in multiple sclerosis

(2018) Claudio Gasperini et al.   NEUROLOGY

Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

(2017) Jessica Frau et al.   JOURNAL OF NEUROLOGY

Is there a change of paradigm towards more effective treatment early in the course of apparent high-risk MS?

(2017) Óscar Fernández   Multiple Sclerosis and Related Disorders

Defining secondary progressive multiple sclerosis

(2016) Johannes Lorscheider et al.   BRAIN

Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis

(2016) Emer Fogarty et al.   Multiple Sclerosis and Related Disorders

Assessment of the reproducibility of oligoclonal IgM band detection for its application in daily clinical practice

(2015) M. Espiño et al.   CLINICA CHIMICA ACTA

Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome

(2013) Diana Ferraro et al.   JOURNAL OF NEUROIMMUNOLOGY

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

(2013) Axel Petzold   JOURNAL OF NEUROIMMUNOLOGY

Response to the letter of Villar et al. ‘Quantitative and qualitative IgM analysis in CSF’

(2011) Hansotto Reiber et al.   Multiple Sclerosis Journal

Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual

(2011) Laurence Durante et al.   Multiple Sclerosis Journal

Comment on the article by Stauch et al. ‘Intrathecal IgM synthesis in paediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis’

(2011) LM Villar et al.   Multiple Sclerosis Journal

Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes

(2011) Maria José Magraner et al.   NEURORADIOLOGY

The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

(2010) I. Boscá et al.   JOURNAL OF NEUROIMMUNOLOGY

Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis

(2010) C Stauch et al.   Multiple Sclerosis Journal

Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM

(2010) Patrizia Sola et al.   Multiple Sclerosis Journal

A multifactorial prognostic index in multiple sclerosis

(2008) J. Mandrioli et al.   JOURNAL OF NEUROLOGY

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis

(2008) M Thangarajh et al.   Multiple Sclerosis Journal